DTAB proposes 10 new drug import points, including Noida airport and ICD Dadri
India’s Drugs Technical Advisory Board has proposed adding 10 import points for drugs, medical devices and cosmetics, including Noida International Airport and ICD Dadri. The move could shorten clearance times and lower logistics costs, subject to an amendment to Rule 43A.
What happened
Drugs Technical Advisory Board (DTAB) · DTAB has proposed Noida International Airport, ICD Dadri and eight other locations as drug, medical-device and cosmetics
Key facts
- 10 new locations
- Rule 43A
- 11 airports
- 42 notified entry points
- 2025
What changed
DTAB has proposed Noida International Airport, ICD Dadri and eight other locations as drug, medical-device and cosmetics import points, aiming to speed clearances and reduce logistics costs. The proposal requires a Rule 43A amendment before implementation.
Why this matters
Retail operators in pharma, medical devices and beauty could gain faster, lower-cost imports if India approves the proposed 10 new drug entry points, but should treat the benefit as contingent on Rule 43A amendment.
What to watch
- Gazette notification amending Rule 43A and final list of authorized import points.
- Operational launch dates for Noida International Airport cargo handling and ICD Dadri drug/device/cosmetic clearance.
- CDSCO, customs and port-specific guidance on documentation, sampling, testing and importer licensing.
- Availability of drug-testing laboratory capacity, inspectors and integrated customs systems at new points.
- Reported clearance times, detention rates and freight quotes versus Mumbai, Chennai, Delhi and other existing gateways.